Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …

The Omicron variant, which has become the dominant strain of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) worldwide, brings new challenges to preventing and …

Background Significant uncertainties remain regarding the utilization of organs for solid
organ transplantation (SOT) from donors with coronavirus disease 2019 (COVID‐19). The …

Objectives The study aim was to assess predictors of negative antibody response (AbR) in
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination …

Solid organ transplant recipients (SOTRs) may be at higher risk of developing severe
coronavirus disease 2019 (COVID-19). 1 Once hospitalized, SOTRs with COVID-19, when …

Purpose: Solid organ transplant recipients (SOTR) have a high risk for severe COVID-19
infection; hence it is necessary to find alternative treatment strategies to protect these …

Background The use and potential benefit of anti-severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs) for the treatment of mild-to …

Kidney transplant recipients (KTR) are at increased risk for COVID-19-associated
complications. We aimed to describe the evolving epidemiology and outcome of PCR …

Abstract Background Lung transplant recipients (LTRs) are at increased risk for coronavirus
disease 2019 (COVID‐19)‐associated complications. Methods We aimed to describe the …

Several cases of fatal pneumonia during November 2019 were linked initially to severe
acute respiratory syndrome coronavirus 2, which the World Health Organization later …